This article relies largely or entirely on a
single source. (April 2021) |
Clinical data | |
---|---|
Other names | CGS-13429 |
Routes of administration | By mouth |
ATC code |
|
Pharmacokinetic data | |
Elimination half-life | 8.1 Hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C16H20N6 |
Molar mass | 296.378 g·mol−1 |
3D model ( JSmol) | |
| |
|
Batelapine (developmental code name CGS-13429) is a structural analogue of clozapine which was investigated as a potential antipsychotic. [1] [2]
This article relies largely or entirely on a
single source. (April 2021) |
Clinical data | |
---|---|
Other names | CGS-13429 |
Routes of administration | By mouth |
ATC code |
|
Pharmacokinetic data | |
Elimination half-life | 8.1 Hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C16H20N6 |
Molar mass | 296.378 g·mol−1 |
3D model ( JSmol) | |
| |
|
Batelapine (developmental code name CGS-13429) is a structural analogue of clozapine which was investigated as a potential antipsychotic. [1] [2]